EcoDrugPlus

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSACLG00000013386
Gene Symbol: LOC113022284
2 Cross references
196 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSACLG00000004337
Gene Symbol: LOC113016786
2 Cross references
1021 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSACLG00000010468
Gene Symbol: LOC113024101
3 Cross references
207 Possible Orthologues:

Matrilysin-Like

Ensembl ID : ENSACLG00000000251
Gene Symbol: LOC113036136
2 Cross references
164 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSACLG00000019878
Gene Symbol: MMP14
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSACLG00000016611
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSACLG00000001873
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSACLG00000011022
Gene Symbol: LOC113018838
3 Cross references
199 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSACLG00000012434
Gene Symbol: MTOR
1 Cross references
222 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSACLG00000006015
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSACLG00000012637
Gene Symbol: MC4R
1 Cross references
211 Possible Orthologues:

Melanoma Receptor Tyrosine-Protein Kinase-Like

Ensembl ID : ENSACLG00000018098
Gene Symbol: LOC113029559
2 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).